225 related articles for article (PubMed ID: 17148749)
1. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects.
Sloth B; Holst JJ; Flint A; Gregersen NT; Astrup A
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1062-8. PubMed ID: 17148749
[TBL] [Abstract][Full Text] [Related]
2. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males.
Sloth B; Davidsen L; Holst JJ; Flint A; Astrup A
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E604-9. PubMed ID: 17566112
[TBL] [Abstract][Full Text] [Related]
3. Effects of PYY3-36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men.
Schmidt JB; Gregersen NT; Pedersen SD; Arentoft JL; Ritz C; Schwartz TW; Holst JJ; Astrup A; Sjödin A
Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1248-56. PubMed ID: 24735885
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man.
Witte AB; Grybäck P; Holst JJ; Hilsted L; Hellström PM; Jacobsson H; Schmidt PT
Regul Pept; 2009 Nov; 158(1-3):57-62. PubMed ID: 19651163
[TBL] [Abstract][Full Text] [Related]
5. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
[TBL] [Abstract][Full Text] [Related]
6. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
van den Hoek AM; Heijboer AC; Voshol PJ; Havekes LM; Romijn JA; Corssmit EP; Pijl H
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E238-45. PubMed ID: 16940471
[TBL] [Abstract][Full Text] [Related]
7. Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats.
Chelikani PK; Haver AC; Reidelberger RD
Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R39-46. PubMed ID: 17428898
[TBL] [Abstract][Full Text] [Related]
8. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
9. Effects of exercise on gut peptides, energy intake and appetite.
Martins C; Morgan LM; Bloom SR; Robertson MD
J Endocrinol; 2007 May; 193(2):251-8. PubMed ID: 17470516
[TBL] [Abstract][Full Text] [Related]
10. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet.
van den Hoek AM; Heijboer AC; Corssmit EP; Voshol PJ; Romijn JA; Havekes LM; Pijl H
Diabetes; 2004 Aug; 53(8):1949-52. PubMed ID: 15277371
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of food intake in obese subjects by peptide YY3-36.
Batterham RL; Cohen MA; Ellis SM; Le Roux CW; Withers DJ; Frost GS; Ghatei MA; Bloom SR
N Engl J Med; 2003 Sep; 349(10):941-8. PubMed ID: 12954742
[TBL] [Abstract][Full Text] [Related]
12. Lean and obese dietary phenotypes: differences in energy and substrate metabolism and appetite.
Clamp L; Hehir AP; Lambert EV; Beglinger C; Goedecke JH
Br J Nutr; 2015 Nov; 114(10):1724-33. PubMed ID: 26382929
[TBL] [Abstract][Full Text] [Related]
13. Total peptide YY is a correlate of postprandial energy expenditure but not of appetite or energy intake in healthy women.
Doucet E; Laviolette M; Imbeault P; Strychar I; Rabasa-Lhoret R; Prud'homme D
Metabolism; 2008 Oct; 57(10):1458-64. PubMed ID: 18803953
[TBL] [Abstract][Full Text] [Related]
14. Effects of whole grain rye, with and without resistant starch type 2 supplementation, on glucose tolerance, gut hormones, inflammation and appetite regulation in an 11-14.5 hour perspective; a randomized controlled study in healthy subjects.
Sandberg JC; Björck IME; Nilsson AC
Nutr J; 2017 Apr; 16(1):25. PubMed ID: 28431559
[TBL] [Abstract][Full Text] [Related]
15. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
[TBL] [Abstract][Full Text] [Related]
16. Short-term aerobic exercise training increases postprandial pancreatic polypeptide but not peptide YY concentrations in obese individuals.
Kanaley JA; Heden TD; Liu Y; Whaley-Connell AT; Chockalingam A; Dellsperger KC; Fairchild TJ
Int J Obes (Lond); 2014 Feb; 38(2):266-71. PubMed ID: 23736355
[TBL] [Abstract][Full Text] [Related]
17. On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans.
Asmar M; Tangaa W; Madsbad S; Hare K; Astrup A; Flint A; Bülow J; Holst JJ
Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E614-21. PubMed ID: 19996386
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity.
Maier C; Riedl M; Vila G; Nowotny P; Wolzt M; Clodi M; Ludvik B; Luger A
Diabetes; 2008 Sep; 57(9):2332-40. PubMed ID: 18567824
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral fat perception by modified sham feeding on energy expenditure, hormones and appetite profile in the postprandial state.
Smeets AJ; Lejeune MP; Westerterp-Plantenga MS
Br J Nutr; 2009 May; 101(9):1360-8. PubMed ID: 18814804
[TBL] [Abstract][Full Text] [Related]
20. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
